Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

100031

	registered interest
	date	21/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to reverse the rise in liver deaths in England between 2001 and 2012 shown by Public Health England’s report <i>Liver Disease Profiles</i>.
	tabling member printed	Lord Avebury
	uin	HL2237
	answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>Public Health England (PHE) has a comprehensive range of action aimed at reducing the incidence and mortality from liver disease. It monitors the incidence, mortality and outcomes of treatment for liver disease and the risk factors: alcohol obesity and Hepatitis B and C. PHE has a wide range of action to tackle unhealthy alcohol consumption, obesity and viral hepatitis through strengthening local action, promoting healthy choices, and giving appropriate information to support healthier lives. <br> <br> In response to the All Party Parliamentary Hepatology Group report PHE has committed to producing a PHE Liver Disease Framework. This will focus on public health action to tackle risk factors for liver disease and inequalities in relation to liver disease. Work has already begun to bring together expertise within PHE on the major risk factors for liver disease (alcohol, hepatitis B and C and obesity), data on liver disease and its risk factors and on death and dying from liver disease. Many of the actions to tackle the major risk factors require a coordinated approach between PHE and NHS England.</p><p> </p><p><br> NHS England is responsible for delivering improvements in outcomes against the NHS Mandate and in line with the NHS Outcomes Framework. NHS England are adopting a broad strategy for delivering improvements in relation to premature mortality, working with commissioners and PHE to support clinical commissioning groups in understanding where local challenges lie and in identifying the evidence in relation to the priorities for reducing mortality at a national level.</p><p> </p> answering member printed Earl Howe question first answered 03/11/2014 11:52:44 answering member 2000 label Biography information for Earl Howe
	tabling member	1665 label Biography information for Lord Avebury

175569

	registered interest
	date	26/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to improve care and treatment for patients with hepatic encephalopathy.
	tabling member printed	Lord Avebury
	uin	HL4412
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England, Public Health England (PHE) and the Department of Health are working jointly with stakeholders to make sure that patients with liver disease, including those who may develop hepatic encephalopathy, are supported. PHE is also working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>There are currently no plans to carry out a clinical audit into services for people with advanced liver disease for all causes. However, liver cancer outcomes for the specialised services which NHS England commissions are currently audited and a national audit of outcome dimensions for the treatment of hepatitis C will be established by NHS England in due course. In addition, PHE is working with the Lancet Commission on Liver Disease to use routine data to investigate elements of care for people with advanced liver disease.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020; and</p><p> </p><p> </p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4413 question first answered 03/02/2015 13:55:48 answering member 2000 label Biography information for Earl Howe
	tabling member	1665 label Biography information for Lord Avebury

175570

	registered interest
	date	26/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they have plans to work with NHS England to ensure that a clinical audit is carried out into services for people with advanced liver disease from all causes.
	tabling member printed	Lord Avebury
	uin	HL4413
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England, Public Health England (PHE) and the Department of Health are working jointly with stakeholders to make sure that patients with liver disease, including those who may develop hepatic encephalopathy, are supported. PHE is also working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>There are currently no plans to carry out a clinical audit into services for people with advanced liver disease for all causes. However, liver cancer outcomes for the specialised services which NHS England commissions are currently audited and a national audit of outcome dimensions for the treatment of hepatitis C will be established by NHS England in due course. In addition, PHE is working with the Lancet Commission on Liver Disease to use routine data to investigate elements of care for people with advanced liver disease.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020; and</p><p> </p><p> </p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines.</p><p> </p> answering member printed Earl Howe grouped question UIN HL4412 question first answered 03/02/2015 13:55:48 answering member 2000 label Biography information for Earl Howe
	tabling member	1665 label Biography information for Lord Avebury

228729

	registered interest
	date	19/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to ensure that people suffering from Lysosomal Acid Lipase Deficiency and other causes of cirrhosis in children are diagnosed as soon as possible and have a suitable route to commissioning that is as streamlined and effective as possible.
	tabling member printed	Baroness Masham of Ilton
	uin	HL5911
	answer	answer is ministerial correction date of answer 26/03/2015 answer text <p>The UK Strategy for Rare Diseases commits all four countries of the United Kingdom to work to achieve reduced times for diagnosis of rare diseases and to work with the National Health Service and clinicians to establish appropriate diagnostic pathways which are accessible to, and understood by, professionals and patients.</p><p> </p><p> </p><p> </p><p>NHS England commissions a highly specialised service for liver disease in children, including cirrhosis resulting from lysosomal acid lipase, from three expert centres in London, Birmingham and Leeds. These long established centres provide a clear referral pathway for expert diagnosis and management.</p> answering member printed Earl Howe question first answered 26/03/2015 12:51:28 answering member 2000 label Biography information for Earl Howe
	tabling member	1850 label Biography information for Baroness Masham of Ilton

385300

	registered interest
	date	24/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether the programme of work for liver disease being developed by Public Health England will include a hepatitis C improvement framework.
	tabling member printed	Baroness Masham of Ilton
	uin	HL783
	answer	answer is ministerial correction date of answer 08/07/2015 answer text <p>NHS England and Public Health England (PHE) are working alongside a coalition of other organisations and patient groups to draft a framework for hepatitis C improvement. This hepatitis C improvement framework will set high level aims for the public health system towards elimination of hepatitis C related liver disease as a significant public health concern.</p><p> </p><p> </p><p> </p><p>The hepatitis C improvement framework will be referred to in PHE’s liver disease framework.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 08/07/2015 14:54:40 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	1850 label Biography information for Baroness Masham of Ilton

386476

	registered interest
	date	30/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government when Public Health England's programme of work on liver disease will be published.
	tabling member printed	Baroness Randerson
	uin	HL971
	answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>Public Health England’s liver disease framework will be published in autumn 2015.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 12:59:16 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	4230 label Biography information for Baroness Randerson

675194

	registered interest
	date	18/01/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what was the incidence of non-alcoholic fatty liver disease in humans in (1) 1990, (2) 1995, (3) 2005, and (4) 2015.
	tabling member printed	The Countess of Mar
	uin	HL4759
	answer	answer is ministerial correction date of answer 27/01/2017 answer text <p>The data is not available in the format requested.</p> answering member printed Lord O'Shaughnessy question first answered 27/01/2017 12:09:25 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar

114840

	registered interest
	date	05/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to his Answer of 23 October 2014 to Question 211147, what the timeline is for publication of the Liver Disease Framework under development by Public Health England; and whether there will be a full public consultation during that process.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	213661
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>Public Health England plans to publish its framework for tackling liver disease in the summer of 2015.</p><p> </p><p> </p><p> </p><p>The framework will lay out clearly the scope of Public Health England activities. This will range from the investigation of hepatitis viruses to support local authorities in their work to tackle the effects of alcohol consumption and obesity on liver disease. It will also cover the life course from antenatal screening, vaccination of babies born, to mothers with chronic Hepatitis B, to improving the care of patients dying from liver disease.</p><p> </p><p> </p><p> </p><p>Public Health England is not intending to hold a formal consultation on the framework but is conducting extensive engagement with a wide range of stakeholders in its development. These include NHS England, the liver disease related charities, hepatologists (liver disease specialists) from across the country and local authority representatives.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 17:08:11 answering member 3918 label Biography information for Jane Ellison
	tabling member	4036 label Biography information for Luciana Berger

171813

	registered interest
	date	02/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to support the early identification of liver disease.
	tabling member constituency	Cheadle
	tabling member printed	Mark Hunter
	uin	219598
	answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>Public Health England (PHE) has a comprehensive range of action aimed at reducing the incidence and mortality from liver disease. It monitors the incidence, mortality and outcomes of treatment for liver disease and the risk factors: alcohol obesity and hepatitis B and C. PHE has a wide range of action to tackle unhealthy alcohol consumption, obesity and viral hepatitis through strengthening local action, promoting healthy choices, and giving appropriate information to support healthier lives.</p><p> </p><p> </p><p> </p><p>In response to the All Party Parliamentary Hepatology Group report PHE has committed to producing a PHE Liver Disease Framework. This will focus on public health action to tackle risk factors for liver disease and inequalities in relation to liver disease. Work has already begun to bring together expertise within PHE on the major risk factors for liver disease (alcohol, hepatitis B and C and obesity), data on liver disease and its risk factors and on death and dying from liver disease. PHE has also issued liver profiles to each local authority area, which include information about hepatitis C, as well as modelling tools to assist local commissioners in establishing need at local level. Many of the actions to tackle the major risk factors require a coordinated approach between PHE and NHS England.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for delivering improvements in outcomes against the NHS Mandate and in line with the NHS Outcomes Framework. NHS England is adopting a broad strategy for delivering improvements in relation to premature mortality, working with commissioners and PHE to support clinical commissioning groups in understanding where local challenges lie and in identifying the evidence in relation to the priorities for reducing mortality at a national level.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/01/2015 13:38:47 answering member 3918 label Biography information for Jane Ellison
	tabling member	1598 label Biography information for Mark Hunter

174744

	registered interest
	date	20/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to support patients with cirrhosis liver conditions.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	uin	221356
	answer	answer is ministerial correction date of answer 27/01/2015 answer text <p>NHS England, Public Health England (PHE) and the Department are working jointly with stakeholders to make sure that patients with liver disease, including cirrhosis, are supported. This work includes taking forward the recommendations of the recent Lancet Commission report on liver disease in the United Kingdom. In addition, PHE is working with stakeholders to develop a liver disease framework.</p><p> </p><p> </p><p> </p><p>We are also taking action to prevent people developing liver disease in the first place by tackling two of the main causes of liver disease – obesity and alcohol misuse. This includes:</p><p> </p><p> </p><p> </p><p>- our Call to Action on Obesity, which sets out two national ambitions for a downward trend in level of excess weight in children and adults by 2020;</p><p> </p><p>- our Alcohol Strategy, which aims to cut the number of people drinking above the lower-risk guidelines; and</p><p> </p><p>- PHE’s five outcome focussed priorities which includes helping people to live longer and more healthy lives by reducing preventable deaths and the burden of ill health associated with, amongst others, alcohol.</p><p> </p><p><strong> </strong></p><p> </p><p>In addition, the National Institute for Health and Care Excellence is developing clinical guidance on the assessment and management of cirrhosis. The guidance is due to be published in May 2016.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/01/2015 12:32:11 answering member 3918 label Biography information for Jane Ellison
	tabling member	1597 label Biography information for David Simpson